Conversely, decreased levels of osteoprotegerin (OR = 0.772; 95% CI: 0.671–0.889; FDR = 0.015) and adenosine deaminase (OR = 0.811; 95% CI: 0.736–0.894; FDR < 0.001) were associated with increased OM risk. The gene discussed is TNFRSF11B; the disease is ocular melanoma.